Risk factors for hepatitis C virus infection in blood donors : a case-control study
OBJECTIVE: To investigate risk factors for hepatitis C virus (HCV) infection in Sydney blood donors.
DESIGN: Blood donors confirmed to be positive for HCV antibodies were compared with blood donors with a positive result of a screening assay, but whose HCV antibody status had not been confirmed. A questionnaire on sexual, parenteral and other potential risk factors was administered to both groups.
SETTING: Blood Transfusion Service in Sydney.
PARTICIPANTS: The study enrolled 220 donors who had confirmed HCV infection, and 210 donors who did not.
RESULTS: The relative risk associated with injecting drug use was 63 (95% confidence interval, 19-260) when comparison was made with all other donors. Among donors who did not report injecting drug use, a significant, independent increase in risk was found in association with having had a tattoo. Among donors who did not give a history of parenteral exposure, there was a significantly greater risk in people with more than one life-time sexual partner than in those with at most one partner.
CONCLUSION: A history of injecting drug use was elicited as the most important risk factor in Sydney blood donors with antibodies to hepatitis C. Having had a tattoo, and an increased number of lifetime sexual partners were also independently associated with HCV infection.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1992 |
---|---|
Erschienen: |
1992 |
Enthalten in: |
Zur Gesamtaufnahme - volume:157 |
---|---|
Enthalten in: |
The Medical journal of Australia - 157(1992), 4 vom: 17. Aug., Seite 227-30 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kaldor, J M [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 01.12.1992 Date Revised 07.01.2021 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM012594253 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM012594253 | ||
003 | DE-627 | ||
005 | 20231221053025.0 | ||
007 | tu | ||
008 | 231221s1992 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0042.xml |
035 | |a (DE-627)NLM012594253 | ||
035 | |a (NLM)1279364 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kaldor, J M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Risk factors for hepatitis C virus infection in blood donors |b a case-control study |
264 | 1 | |c 1992 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 01.12.1992 | ||
500 | |a Date Revised 07.01.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: To investigate risk factors for hepatitis C virus (HCV) infection in Sydney blood donors | ||
520 | |a DESIGN: Blood donors confirmed to be positive for HCV antibodies were compared with blood donors with a positive result of a screening assay, but whose HCV antibody status had not been confirmed. A questionnaire on sexual, parenteral and other potential risk factors was administered to both groups | ||
520 | |a SETTING: Blood Transfusion Service in Sydney | ||
520 | |a PARTICIPANTS: The study enrolled 220 donors who had confirmed HCV infection, and 210 donors who did not | ||
520 | |a RESULTS: The relative risk associated with injecting drug use was 63 (95% confidence interval, 19-260) when comparison was made with all other donors. Among donors who did not report injecting drug use, a significant, independent increase in risk was found in association with having had a tattoo. Among donors who did not give a history of parenteral exposure, there was a significantly greater risk in people with more than one life-time sexual partner than in those with at most one partner | ||
520 | |a CONCLUSION: A history of injecting drug use was elicited as the most important risk factor in Sydney blood donors with antibodies to hepatitis C. Having had a tattoo, and an increased number of lifetime sexual partners were also independently associated with HCV infection | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Hepatitis Antibodies |2 NLM | |
650 | 7 | |a Hepatitis C Antibodies |2 NLM | |
700 | 1 | |a Archer, G T |e verfasserin |4 aut | |
700 | 1 | |a Buring, M L |e verfasserin |4 aut | |
700 | 1 | |a Ismay, S L |e verfasserin |4 aut | |
700 | 1 | |a Kenrick, K G |e verfasserin |4 aut | |
700 | 1 | |a Lien, A S |e verfasserin |4 aut | |
700 | 1 | |a Purusothaman, K |e verfasserin |4 aut | |
700 | 1 | |a Tulloch, R |e verfasserin |4 aut | |
700 | 1 | |a Bolton, W V |e verfasserin |4 aut | |
700 | 1 | |a Wylie, B R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Medical journal of Australia |d 1945 |g 157(1992), 4 vom: 17. Aug., Seite 227-30 |w (DE-627)NLM000007927 |x 1326-5377 |7 nnns |
773 | 1 | 8 | |g volume:157 |g year:1992 |g number:4 |g day:17 |g month:08 |g pages:227-30 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 157 |j 1992 |e 4 |b 17 |c 08 |h 227-30 |